BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23589040)

  • 1. Roles of GINS2 in K562 human chronic myelogenous leukemia and NB4 acute promyelocytic leukemia cells.
    Gao Y; Wang S; Liu B; Zhong L
    Int J Mol Med; 2013 Jun; 31(6):1402-10. PubMed ID: 23589040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
    Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
    J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer.
    Chi F; Wang Z; Li Y; Chang N
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E; Lillehaug JR; Naoe T; Lanotte M
    Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
    Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
    Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of GINS2 on proliferation and apoptosis in leukemic cell line.
    Zhang X; Zhong L; Liu BZ; Gao YJ; Gao YM; Hu XX
    Int J Med Sci; 2013; 10(12):1795-804. PubMed ID: 24273454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
    Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
    J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
    Lai HK; Borden KL
    Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of PML(NLS-) gene mediated by recobinant adenovirus vector on emodin-induced apoptosis of HL-60 cells].
    Gao YM; Liu BZ; Zhang X; Hu XX; Zhong L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):703-7. PubMed ID: 24325094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML.
    Chan JY; Li L; Fan YH; Mu ZM; Zhang WW; Chang KS
    Biochem Biophys Res Commun; 1997 Nov; 240(3):640-6. PubMed ID: 9398618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
    Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
    Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfection of promyelocytic leukemia in retrovirus vector inhibits growth of human bladder cancer cells.
    Li L; He DL
    Acta Pharmacol Sin; 2005 May; 26(5):610-5. PubMed ID: 15842782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
    Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.
    Ikeda T; Kimura F; Nakata Y; Sato K; Ogura K; Motoyoshi K; Sporn M; Kufe D
    Cell Death Differ; 2005 May; 12(5):523-31. PubMed ID: 15746941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
    Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
    Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
    Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of NFAT by promyelocytic leukemia protein.
    Lo YH; Wu CC; Shih HM; Lai MZ
    Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
    Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
    Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.